Dataset Open Access
Gündel, Daniel;
Teodoro, Rodrigo;
Ludwig, Friedrich-Alexander;
Heerklotz, Anne;
Toussaint, Magali;
Deuther-Conrad, Winnie;
Bormans, Guy;
Brust, Peter;
Kopka, Klaus;
Moldovan, Rares-Petru
What is already known • Increased expression of the CB2R in the brain is linked to certain neuropathological diseases. • First clinical trials for CB2R-directed therapies are conducted. What this study adds • [18F]JHU94620-d8 provides the potential to quantify the CB2R receptor density in the brain by positron-emission-tomography. Clinical significance • Stratification of patients for CB2R-directed therapies and follow up of the treatment response is needed.
| Name | Size | |
|---|---|---|
|
18FJHU94620_gammacounter_results15Jan2020.xlsx
md5:55b39f77b300f1f1cbfdace12f5ea7cf |
15.4 kB | Download |
| All versions | This version | |
|---|---|---|
| Views | 642 | 642 |
| Downloads | 52 | 52 |
| Data volume | 802.7 kB | 802.7 kB |
| Unique views | 596 | 596 |
| Unique downloads | 52 | 52 |